← FDA Drug Approvals (Drugs@FDA)

ROZLYTREK

NDA · New Drug Application · Sponsor: GENENTECH INC · Approved 2019-08-15

Drug application

FDA Application #

NDA212726

Application type

New Drug Application

Brand name

ROZLYTREK

Generic name

Entrectinib

Active ingredients

ENTRECTINIB

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

GENENTECH INC

First approval

2019-08-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown